CVS Health Corporation [CVS] is -5.77% lower this YTD. Is it still time to buy?

CVS Health Corporation [NYSE: CVS] traded at a low on 09/27/22, posting a -0.54 loss after which it closed the day’ session at $97.21. The company report on September 27, 2022 that CVS Health supporting customers, patients, members and colleagues as Hurricane Ian approaches.

China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.


CVS Health® (NYSE: CVS) is actively preparing for Hurricane Ian’s landfall in Florida this week. The company’s priority is the health and safety of its colleagues, customers, and members, and it is committed to providing its communities access to the products and services they need to plan for the storm.

In advance of Hurricane Ian, CVS Health is implementing proactive measures across its businesses to ensure continuity of care.

The results of the trading session contributed to over 4590067 shares changing hands. Over the past one week, the price volatility of CVS Health Corporation stands at 2.40% while the volatility over the past one month is 2.01%.

The market cap for CVS stock reached $129.54 billion, with 1.31 billion shares outstanding and 1.31 billion shares in the current float. Compared to the average trading volume of 4.71M shares, CVS reached a trading volume of 4590067 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about CVS Health Corporation [CVS]?

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CVS shares is $120.57 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CVS stock is a recommendation set at 2.10. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Loop Capital have made an estimate for CVS Health Corporation shares, keeping their opinion on the stock as Buy, with their previous recommendation back on June 17, 2022. While these analysts kept the previous recommendation, Bernstein dropped their target price from $122 to $112. The new note on the price target was released on May 27, 2022, representing the official price target for CVS Health Corporation stock. Previously, the target price had yet another raise to $110, while Deutsche Bank analysts kept a Hold rating on CVS stock.

The Average True Range (ATR) for CVS Health Corporation is set at 2.07, with the Price to Sales ratio for CVS stock in the period of the last 12 months amounting to 0.42. The Price to Book ratio for the last quarter was 1.70, with the Price to Cash per share for the same quarter was set at 11.25. Price to Free Cash Flow for CVS in the course of the last twelve months was 9.90 with Quick ratio for the last quarter at 0.70.

How has CVS stock performed recently?

CVS Health Corporation [CVS] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -4.08. With this latest performance, CVS shares dropped by -2.85% in over the last four-week period, additionally sinking by -10.02% over the last 6 months – not to mention a rise of 13.38% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CVS stock in for the last two-week period is set at 37.33, with the RSI for the last a single of trading hit 29.54, and the three-weeks RSI is set at 42.18 for CVS Health Corporation [CVS]. The present Moving Average for the last 50 days of trading for this stock 100.23, while it was recorded at 98.58 for the last single week of trading, and 100.63 for the last 200 days.

CVS Health Corporation [CVS]: Deeper insight into the fundamentals

Operating Margin for any stock indicates how profitable investing would be, and CVS Health Corporation [CVS] shares currently have an operating margin of +5.12 and a Gross Margin at +17.77. CVS Health Corporation’s Net Margin is presently recorded at +2.71.

Return on Equity for this stock inclined to 10.95, with Return on Assets sitting at 3.30.

CVS Health Corporation’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.70 and a Current Ratio set at 0.90.

Earnings analysis for CVS Health Corporation [CVS]

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CVS. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for CVS Health Corporation go to 6.34%.

Insider trade positions for CVS Health Corporation [CVS]

There are presently around $100,560 million, or 80.40% of CVS stock, in the hands of institutional investors. The top three institutional holders of CVS stocks are: VANGUARD GROUP INC with ownership of 114,208,329, which is approximately 2.094% of the company’s market cap and around 0.20% of the total institutional ownership; BLACKROCK INC., holding 94,478,091 shares of the stock with an approximate value of $9.18 billion in CVS stocks shares; and CAPITAL WORLD INVESTORS, currently with $5.72 billion in CVS stock with ownership of nearly 0.346% of the company’s market capitalization.

Positions in CVS Health Corporation stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 1,058 institutional holders increased their position in CVS Health Corporation [NYSE:CVS] by around 55,492,479 shares. Additionally, 1,149 investors decreased positions by around 47,657,497 shares, while 260 investors held positions by with 931,311,895 shares. The mentioned changes placed institutional holdings at 1,034,461,871 shares, according to the latest SEC report filing. CVS stock had 111 new institutional investments in for a total of 6,122,536 shares, while 145 institutional investors sold positions of 4,033,000 shares during the same period.


Please enter your comment!
Please enter your name here